SPOTLIGHT: Phillipines courts Indian pharma

Please, please, please bring your plants here. The Phillipines is targeting India's fast-growing pharma industry with tax incentives and duty exemptions, hoping to get more cheap drugs into the hands of its poor. President Gloria Macapagal-Arroyo announced the investment incentives in Mumbai, saying her country is "bullish on 21st century India." Welcome to the party, Madam President. Report

Suggested Articles

Pfizer's diagnosis-focused launch strategy for Vyndaqel and Vyndamax is paying off with the meds reaching thousands of patients already.

Pfizer terminated a slew of trial cohorts testing Bavencio in combination with its own experimental drugs, as well as one monotherapy trial.

With its Eli Lilly-partnered Olumiant nearing filing in atopic dermatitis, Incyte's other JAK med Jakafi is also looking for a win in that indication.